Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

7.18

+0.27 (3.91%)

At close: Oct 15, 2026, 4:00 PM EDT

7.18

0.00 (-0.04%)

After-hours: Oct 15, 2026, 7:30 PM EDT

Emergent BioSolutions Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	770.2	742.9	1,044	1,049	1,118	1,774
Revenue Growth	-9.56%	-28.81%	-0.54%	-6.10%	-36.99%	12.45%
Gross Profit	388.5	367.3	311.6	254.2	290.1	793.2
Operating Income	140.5	115.6	-52.2	-168.1	-109.3	386
Net Income	-176.8	52.6	-190.6	-760.5	-211.6	219.5
Earnings Per Share	-3.39	0.93	-3.60	-14.85	-4.22	4.06
EPS Growth	-	-	-	-	-	-28.52%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Commercial Products	208.6	226.1	398.9	497.3	386.6	438
Mcm Products	511.5	456.7	509.8	447.2	579.6	585.9
Other	50.1	60.1	134.9	104.8	-	-
Total	770.2	742.9	1,044	1,049	1,118	1,774

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	139.7	205.4	99.5	111.7	651.1	576.1
Total Debt	588.2	583.7	676.1	877.5	1,426	877.1
Net Cash (Debt)	-448.5	-378.3	-576.6	-765.8	-775.3	-301
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8.59	-6.67	-10.88	-14.96	-15.48	-5.56

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	97.7	170.6	58.7	-206.3	-34.1	320.2
Capital Expenditures	-11.8	-13.8	-22.9	-51.6	-115.8	-224.1
Free Cash Flow	85.9	156.8	35.8	-257.9	-149.9	96.1
Free Cash Flow Growth	-44.58%	337.99%	-	-	-	-75.67%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	50.44%	49.44%	29.86%	24.23%	25.96%	44.72%
Operating Margin	18.24%	15.56%	-5.00%	-16.02%	-9.78%	21.76%
Pretax Margin	-18.96%	11.15%	-13.69%	-69.68%	-19.60%	17.10%
Profit Margin	-22.96%	7.08%	-18.26%	-72.48%	-18.93%	12.38%
FCF Margin	11.15%	21.11%	3.43%	-24.58%	-13.41%	5.42%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	12.34	-	-	-	10.65
Forward PE	10.15	4.16	12.57	20.50	51.15	7.19
P/FCF Ratio	4.29	4.14	14.47	-	-	24.34
PS Ratio	0.48	0.87	0.50	0.12	0.53	1.32